SCHEMBL412255

SCHEMBL412255

CC(=O)Cn1ccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682316 0.82
SCHEMBL7241523 0.82 ALDH1A1 (0.72)
SCHEMBL77978 0.80
SCHEMBL2695815 0.79 ALDH1A1 (0.62)
SCHEMBL4288375 0.79 ALDH1A1 (0.62)
SCHEMBL4288379 0.79 EGLN3 (0.69)
SCHEMBL12391736 0.79 ALDH1A1 (0.62)
SCHEMBL1179222 0.78
SCHEMBL85945 0.78
Hydrochloric Acid SCHEMBL1904485 0.78 ALDH1A1 (0.96)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200166526-A1 METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BEAUMONT HOSPITAL WILLIAM (US) 2020-05-28 US claimed
WO-2019023239-A1 METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE WILLIAM BEAUMONT HOSPITAL (US) 2019-01-31 WO claimed
CN-102516128-A Synthetic technology of diphenylmethane dicarbamate by adopting Bronsted-Lewis acidic ionic liquid catalysis UNIV HEBEI TECHNOLOGY 2012-06-27 CN claimed
EP-2173740-A1 HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM Osta Biotechnologies (CA) 2010-04-14 EP claimed
US-20090176831-A1 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System OSTA BIOTECHNOLOGIES (CA) 2009-07-09 US claimed
WO-2008151437-A1 HEME-OXYGENASE INHIBITORS AND USE OF THE SAME IN THE TREATMENT OF CANCER AND DISEASES OF THE CENTRAL NERVOUS SYSTEM OSTA BIOTECHNOLOGIES (CA) 2008-12-18 WO claimed
US-11737463-B2 Pyridine and pyrazine compounds BASF SE (DE) 2023-08-29 US disclosed
CN-116332929-A 3-amido-beta-carboline compound, preparation method and application thereof 中国科学院上海药物研究所 2023-06-27 CN disclosed
CN-113683944-A Production process of water-bubble-resistant corrosion-resistant stone-like paint 安徽众雁涂料有限公司 2021-11-23 CN disclosed
WO-2021129629-A1 ZESTE ENHANCER HOMOLOGUE 2 INHIBITOR AND USE THEREOF 四川海思科制药有限公司 2021-07-01 WO disclosed
US-20200166526-A1 METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BEAUMONT HOSPITAL WILLIAM (US) 2020-05-28 US disclosed
US-20200166526-A1 METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BEAUMONT HOSPITAL WILLIAM (US) 2020-05-28 US disclosed
EP-2917212-B1 ANTIMICROBIAL AGENTS UNIV RUTGERS (US) 2019-06-12 EP disclosed
US-20070105919-A1 adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-05-10 US disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed
EP-1336612-B1 NOVEL CARBAPENEM DERIVATIVES MEIJI SEIKA KAISHA (JP) 2007-01-17 EP disclosed
CN-1671662-A Piperidine derivatives, process for their preparation and their use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-09-21 CN disclosed
EP-0111384-B1 THIOKETAL SUBSTITUTED N-ALKYL IMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SYNTEX (U.S.A.) INC. (US) 1987-04-22 EP disclosed
US-4489087-A Spermicidal thioketal substituted N-alkyl imidazoles SYNTEX (U.S.A.) INC. (US) 1984-12-18 US disclosed
EP-0111384-A1 Thioketal substituted N-alkyl imidazoles and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1984-06-20 EP disclosed